Provider-verified vaccination records obtained from a pilot study conducted in 14-29-year-old patients were utilized to determine the sensitivity and specificity of the self/parent-reported vaccination data.
The authors concluded, “There is high-certainty evidence that HPV vaccines protect against cervical precancer in adolescent girls and young women aged 15 to 26,” while also indicated that future studies should have long-term follow-up.
Overall prevalence 11.5 percent in men, 3.2 percent in women; high-risk HPV also more prevalent in men
Global study supports revised regimen for those under 15
This patient information fact sheet provides information on the definition, symptoms, causes, diagnostic tests, and treatments for sexually transmitted diseases (STDs).
This patient information fact sheet provides information on the definition, causes, symptoms, and treatments for genital warts.
